期刊
CANCER
卷 97, 期 11, 页码 2806-2813出版社
JOHN WILEY & SONS INC
DOI: 10.1002/cncr.11409
关键词
blood-brain barrier disruption; brain damage; magnetic resonance imaging; metastatic brain tumor
类别
资金
- NHLBI NIH HHS [R01 HL051614, HL51614] Funding Source: Medline
- NINDS NIH HHS [R01 NS043284, R01 NS049514, R01 NS038195, NS43284, NS38195] Funding Source: Medline
BACKGROUND. Sloop protein is expressed constitutively by brain astrocytes. Elevated S100beta levels in cerebrospinal fluid and serum reported after head trauma, subarachnoid hemorrhage, and stroke were correlated with the extent of brain damage. Because elevated serum Sloop also was shown to indicate blood-brain barrier (BBB) dysfunction in the absence of apparent brain injury, it remains unclear whether elevation of serum levels of Sloop reflect BBB dysfunction, parenchyrnal damage, or both. METHODS. The authors conducted a prospective study of serum S100beta levels in six patients who underwent hyperosmotic BBB disruption (BBBD) with intraarterial chemotherapy for primary central nervous system lymphoma. In addition, 53 serum S100beta samples were measured in 51 patients who had a variety of primary or metastatic brain lesions at the time of neuroirnaging. RESULTS. S100beta was correlated directly with the degree of clinical and radiologic signs of BBBD in patients who were enrolled in the hyperosmotic study. In patients with neoplastic brain lesions, gadolinium. enhancement on a magnetic resonance image was correlated with elevated S100beta levels (n = 45 patients; 0.16 +/- 0.1 mug/L; mean +/- standard error of the mean) versus nonenhancing scans (n = 8 patients; 0.069 +/- 0.04 mug/L). Primary brain tumors (n = 8 patients; 0.12 +/- 0.08) or central nervous system metastases also presented with elevated serum S100beta levels (n = 27 patients; 0.14 +/- 0.34). Tumor volume was correlated with serum S100beta levels only in patients with vestibular schwannoma (n = 6 patients; 0.13 +/- 0.10 mug/L) but not in patients with other brain lesions. CONCLUSIONS. S100beta was correlated directly with the extenet and temporal sequence of hyperosmotic BBBD, further suggesting that Sloop is a marker of BBB function. Elevated S100beta levels may indicate the presence of radiologically detectable BBB leakage. Larger prospective studies may better determine the true specificity of Sloop as a marker for BBB function and as an early detection or follow-up marker of brain tumors. (C) 2003 American Cancer Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据